Last update June 10, 2018
Compatible
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Maternal Hepatitis A Infection in other languages or writings:
Maternal Hepatitis A Infection belongs to this group or family:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by La Liga de la Leche de México of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Although IgM and IgG antibodies and, occasionally, hepatitis A virus RNA have been detected in breastmilk, there have been no cases of vertical mother-infant transmission through breastmilk (Chaudhry 2015, Daudi 2012, Selander 2009, Stiehm 2001).
Therefore, and given the benefits of breastfeeding, it is recommended that all mothers with hepatitis A continue breastfeeding (Chaudhry 2015, Garcia 2015, Daudi 2012, Sookoian 2006). Unless the mother is very unwell, breastfeeding can continue without being interrupted.
It is very important to take the appropriate sanitary measures to minimize the risk of fecal-oral transmission to the breastfeeding baby: hand washing should be frequent especially the first 3 to 4 weeks that there is elimination of virus.
If the mother's infection is recent (fewer than 15 days), the infant should be protected with a vaccine or with standard immunoglobulin (Daudi 2012, CDC 1990).
See below the information of these related products: